Science Explorer Back to mapMap
Discussion
Researcher · University of Utah · United States

Ira Lignugaris Kraft

Ira Lignugaris Kraft publishes mostly in Hematology, Genetics and Genetics, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Acute Myeloid Leukemia Research.

ORCID 0000-0001-9669-3291 OpenAlex
World rank
#1,809,525
of 7,710,434 ranked researchers
Rank in United States
#555,693
of 1,627,098
Works
66
Citations
1.1k
Citations per work
16.1
h-index
13
i10-index 13Top 45% in Hematology
Ira Lignugaris Kraft

What does Ira Lignugaris Kraft research?

Ira Lignugaris Kraft's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 35 works · 52.6% of their workMedicine: 35 works · 52.6% of their workHematology: 17 works · 25.3% of their workGenetics: 9 works · 14.1% of their workOncology: 5 works · 8.1% of their workPublic Health, Environmental and Occupational Health: 3 works · 5.1% of their workEverything else: 22 works · 33.2% of their workLife Sciences: 9 works · 14.2% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 14.2% of their workGenetics: 5 works · 8.1% of their workMolecular Biology: 4 works · 6.1% of their workTHEIR WORKIra LignugarisKraft66works
Life Sciences14%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3552.6%
  2. Everything else2233.2%
    1. Biochemistry, Genetics and Molecular Biology914.2%
  1. 1Hematology25% of their works
  2. 2Genetics14% of their works
  3. 3Genetics8% of their works
  4. 4Oncology8% of their works
  5. 5Molecular Biology6% of their works
  6. 6Public Health, Environmental and Occupational Health5% of their works

Research topics

Which keywords describe Ira Lignugaris Kraft's research?

The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations, Hematopoietic Stem Cells, Acute Myeloid Leukemia and AML.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors202 topics
  2. BCR-ABL161 topic
  3. Imatinib161 topic
  4. Chronic Lymphocytic Leukemia121 topic
  5. Genomic Aberrations121 topic
  6. Hematopoietic Stem Cells112 topics
  7. AML81 topic
  8. Acute Myeloid Leukemia81 topic
  9. Cancer Genomics41 topic
  10. Differentiated Thyroid Cancer41 topic
  11. Fusion Genes41 topic
  12. Genetic Variants41 topic
  13. Hypereosinophilic Syndrome41 topic
  14. Mutational Signatures41 topic
  15. Sequence Interpretation41 topic
  16. Thyroid Nodules41 topic
  17. Genetic Mutations31 topic
  18. Neutropenia31 topic

Where does Ira Lignugaris Kraft work?

Ira Lignugaris Kraft's main affiliation in the publication record is University of Utah, United States.

How many publications and citations does Ira Lignugaris Kraft have?

OpenAlex counts 66 works and 1,062 citations for Ira Lignugaris Kraft, an h-index of 13, ranking #1,809,525 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ira Lignugaris Kraft. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.